These drugs include ipilimumab (Yervoy®), an anti-CTLA-4 monoclonal antibody indicated for the treatment of advanced melanoma (83) or azacitidine (Vidaza®), a chemotherapy drug used in the treatment of some types of myelodysplastic syndromes and leukemia (84). This evidence concerns the gene CTLA4 and leukemia.